MX1 - Management Update & Convertible Note Issue
Filed with ASX · · 9 pages · English
Summary by 6ix AI
Micro-X Ltd. has announced the appointment of Brian Gonzales as CEO and a strategic reset focusing on medical CT technology, alongside securing convertible note financing commitments. The strategic reset aims to enhance financial discipline and accountability while prioritizing the development of medical CT products. The financing will also facilitate the commercial launch of the updated Rover and cover operating costs and general working capital.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
In the deck
Earlier from Micro-X
- MX1 - Micro-X Completes Full Body CT Critical Design Review
- MX1 - Human Imaging Study Commences with Micro-X Head CT
- $1.3m Checkpoint Contract Extension Awarded by DHS
- MX1 - First Full Body CT Laboratory Test Bench Completed
- MX1 - December 2025 Half Year Results Presentation
Later from Micro-X
- MX1 - 2026 Appendix 4E and Annual Report
- Response to ASX Price Query
- MX1 - DHS CT Baggage Scanner Contract Extension
- MX1 - Quarterly Activities Report & Appendix 4C
Follow Micro-X into a list and get an email when it puts out news.
Follow Micro-X